三苯双脒治疗华支睾吸虫病的效果观察

doi:10.3969/j.issn.1672-2302.2023.01.009

摘要/Abstract

摘要：

目的观察三苯双脒抗华支睾吸虫的临床疗效，为治疗华支睾吸虫病的药物选择提供依据。方法采用分层随机抽样，将2020年8月—2022年8月南宁市武鸣区疾控中心门诊治疗的华支睾吸虫感染患者分为采用三苯双脒治疗的试验组和采用吡喹酮治疗的对照组，其中试验组分A、B、C三组：A组为单剂次顿服；B组为2剂次隔周顿服；C组为3剂次连续3日顿服。每剂次剂量均为400 mg。对照组（D组）使用吡喹酮治疗，每日3次，800 mg/次，连服3日。治疗一个月后复诊复检，观察治疗前后虫卵变化及药物不良反应，评定治疗效果。结果三苯双脒试验组149例，其中A组45例，B组51例，C组53例；吡喹酮对照组99例。试验组A、B、C各组虫卵阴转率分别为86.67%、94.12%和92.45%；对照组虫卵阴转率为97.98%。各组间虫卵阴转率差异无统计学意义（χ²=7.146，P >0.05）。轻度感染患者试验组A、B、C各组虫卵减少率分别为79.27%、88.47%和82.11%，对照组为87.91%；中度感染患者试验组各组虫卵减少率分别为78.86%、97.43%和98.65%，对照组为99.15%。试验组总不良反应发生率和不良反应平均持续时间分别为5.37%和3.9 h；对照组不良反应发生率和平均持续时间分别为13.13%和50.9 h，两组不良反应发生率及平均持续时间差异均有统计学意义（χ²=4.624，t=6.423，P均<0.05）。结论三苯双脒治疗华支睾吸虫有较好疗效，不良反应发生率和持续时间低于吡喹酮，可应用于临床治疗华支睾吸虫病。

关键词: 三苯双脒, 吡喹酮, 华支睾吸虫病, 疗效

Abstract:

Objective To observe the clinical efficacy of triphenylamidine against Clonorchis sinensis for evidence to screen the optimal drug in the treatment of clonorchiasis. Methods By stratified random sampling, patients infected with Clonorchis sinensis, treated in the outpatient department of Wuming District Disease Prevention and Control Center of Nanning City, were included from August 2020 to August 2022, and divided into observational group (treated with tribendimidine) and control group (treated with praziquantel). Then patients in the observational group were sub-grouped into group A (400 mg, single dose), group B (two doses of daily dose every other week), and group C (three doses for three consecutive days). Patients in the control group (group D) were was treated with praziquantel in dose of 800 mg/time, tid, for 3 days. After one month of medication, all patients underwent reexamination to observe the changes of worm eggs and adverse drug reactions before and after treatment, and treatment effect was evaluated. Results In total, 149 patients received medication with tribendimidine, including 45 patients in group A, 51 in group B, and 53 in group C. Ninety-nine patients were treated with praziquantel. Negative conversion rate in for the egg the observational group was 86.67%, 94.12% and 92.45% respectively, and 97.98% for the control group. There was no significant difference in the conversion rate among groups (χ²=7.146, P>0.05). The egg reduction rate was 79.27%, 88.47% and 82.11% in the three sub-groups, respectively, and 87.91% in the control group for patients with mild infection. For patients with moderate infection, the egg reduction rate was 78.86%, 97.43% and 98.65% in the tribendimidine group, and 99.15% in the praziquantel control group. The total incidence of adverse reaction and the average duration of adverse reaction were 5.37% and 3.9 h, and 13.13% and 50.9 h, respectively in the observational group and control group. The incidence and average duration of adverse reaction were lower in the tribendimidine group than in the praziquantel group, with statistical significance (χ²=4.624, t=6.423, both P<0.05). Conclusion Tribenzamidine can be used for clonorchiasis in clinic, because it shows better efficacy and has has lower incidence and duration of adverse reaction compared to praziquantel.

Key words: Tribenzamidine, Praziquantel, Clonorchiasis, Curative effect

中图分类号:

R532.23

黄星炯, 黄显泽, 班贡生, 陆丽艳, 梁美群, 林世保. 三苯双脒治疗华支睾吸虫病的效果观察[J]. 热带病与寄生虫学, 2023, 21(1): 48-51.

HUANG Xing-jiong, HUANG Xian-ze, BAN Gong-sheng, LU Li-yan, LIANG Mei-qun, LIN Shi-bao. Observation on the efficacy of different doses of tribendimidine for patients with clonorchiasis[J]. Journal of Tropical Diseases and Parasitology, 2023, 21(1): 48-51.

图/表 3

表1

表2

表3

参考文献 18

[1]	许隆祺, 陈颖丹, 孙凤华, 等. 全国人体重要寄生虫病现状调查报告[J]. 中国寄生虫学与寄生虫病杂志, 2005, 23(增刊1):332-340.
[2]	陈颖丹, 周长海, 朱慧慧, 等. 2015年全国人体重点寄生虫病现状调查分析[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(1):5-16.
[3]	钱门宝, 朱慧慧, 陈颖丹, 等. 中国华支睾吸虫病药物治疗现状分析[J]. 中国血吸虫病防治杂志, 2018, 30(5):513-517.
[4]	徐莉莉, 姜斌, 周晓农. 抗华支睾吸虫药物研究进展[J]. 国际医学寄生虫病杂志, 2013, 40(4):212-215.
[5]	蒋智华, 张鸿满, 黎学铭, 等. 三苯双脒、青蒿琥酯和吡喹酮单药或联合用药治疗华支睾吸虫病的疗效观察[J]. 应用预防医学, 2012, 18(5):264-268.
[6]	肖树华, 吴惠敏, 王翀. 三苯双脒——一种新的广谱抗肠道蠕虫新药[J]. 中国寄生虫学与寄生虫病杂志, 2004, 22(5):312-315.
[7]	方悦怡, 梁文佳, 张启明, 等. 三苯双脒肠溶片治疗肠道线虫感染的效果观察[J]. 中国血吸虫病防治杂志, 2002, 14(2):125-127.
[8]	张剑辉, 肖树华, 吴中兴, 等. 三苯双脒肠溶片治疗1292例肠道线虫感染者Ⅳ期临床试验[J]. 中国寄生虫学与寄生虫病杂志, 2008, 26(1):6-9.
[9]	唐莉娜, 王世海, 陈兆义, 等. 三苯双脒肠溶片治疗儿童蛔虫、钩虫、鞭虫疗效观察[J]. 中国人兽共患病学报, 2008, 24(7):681-682.
[10]	肖树华, 薛剑, 吴中兴. 三苯双脒、青蒿琥酯和蒿甲醚抗华支睾吸虫及其他吸虫的实验研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2009, 27(1):65-69.
[11]	Xu LL, Jiang B, Duan JH, et al. Efficacy and safety of praziquantel, tribendimidine and mebendazole in patients with co-infection of Clonorchis sinensis and other helminths[J]. PLoS Negl Trop Dis, 2014, 8(8):e3046. doi: 10.1371/journal.pntd.0003046 URL
[12]	姚甲凯, 戴建荣. 华支睾吸虫病的流行及治疗现状[J]. 中国病原生物学杂志, 2020, 15(3):364-370.
[13]	黄星炯, 梁美群, 张国汉, 等. 吡喹酮治疗4289例华支睾吸虫感染患者效果分析[J]. 热带医学杂志, 2021, 21(7):933-935.
[14]	薛剑, 徐莉莉, 强慧琴, 等. 用三苯双脒、吡喹酮和青蒿琥酯临床给药方案治疗感染华支睾吸虫大鼠的研究[J]. 中国寄生虫学与寄生虫病杂志, 2010, 28(3):166-171.
[15]	姜斌, 陶奕, 徐莉莉, 等. 三苯双脒在大鼠血浆和胆汁中代谢动力学研究[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(5):449-454.
[16]	黄星炯, 张国汉, 梁美群, 等. 吡喹酮治疗门诊华支睾吸虫病患者的疗效观察[J]. 热带病与寄生虫学, 2021, 19(4):224-226.
[17]	黎团, 侯俊, 潘定全. 吡喹酮在治疗肝吸虫病中常见的不良反应及其对策[J]. 临床医药文献电子杂志, 2018, 5(12):160-161.
[18]	冯强, 罗乐, 夏生林, 等. 两种驱虫药治疗华支睾吸虫病的疗效比较[J]. 热带医学杂志, 2006, 6(12):1291-1292.

治疗分组	治疗人数	性别		年龄（岁）	轻度感染		中度感染
治疗分组	治疗人数	男	女	年龄（岁）	人数	平均EPG	人数	平均EPG
A组	45	25	20	45.42±10.41	42	283.49	3	1 538.32
B组	51	32	19	47.57±12.64	43	323.05	8	3 959.87
C组	53	35	18	47.60±12.20	44	339.11	9	2 353.72
D组	99	65	34	49.81±11.01	82	386.16	17	4 077.65

治疗分组	轻度感染				中度感染
治疗分组	人数	治疗前平均EPG	治疗后平均EPG	虫卵减少率（%）	人数	治疗前平均EPG	治疗后平均EPG	虫卵减少率（%）
A组	5	532.68	110.41	79.27	1	1 022.00	216.00	78.86
B组	2	208.08	24.00	88.47	1	4 362.00	112.00	97.43
C组	2	874.57	156.46	82.11	2	3 329.66	44.90	98.65
D组	1	794.00	96.00	87.91	1	5 642.00	48.00	99.15